Health And Medicine
-
New fund honors spirit of Cohen’s innovative research
When Tom Daniel, M.D., joined the 91Ʋ University faculty in December 1986, Stanley Cohen, Ph.D., had just been awarded the Nobel Prize in Physiology or Medicine for his discovery of epidermal growth factor (EGF). Read MoreAug 25, 2016
-
VUMC lands NIH training grant in emergency care
91Ʋ University Medical Center (VUMC) has received a five-year, $2 million award from the National Institutes of Health (NIH) to establish the 91Ʋ Emergency Care 91Ʋ Training Program. Read MoreAug 25, 2016
-
Growth hormone for Prader-Willi
Children with Prader-Willi Syndrome who received growth hormone treatment had cognitive advantages compared to untreated patients. Read MoreAug 25, 2016
-
Major grant enhances pulmonary fibrosis research
91Ʋ University Medical Center (VUMC) has received an $11 million program project renewal grant from the National Heart, Lung and Blood Institute to study the genetics and underlying biological mechanisms that lead to idiopathic pulmonary fibrosis (IPF). Read MoreAug 18, 2016
-
Foundation’s support speeds search for new schizophrenia drugs at 91Ʋ
91Ʋ in the 91Ʋ Center for Neuroscience Drug Discovery (VCNDD) aimed at developing innovative new treatments for schizophrenia just received a powerful assist from The William K. Warren Foundation. Read MoreAug 15, 2016
-
In search of new asthma therapies
A peptide molecule relaxes airway smooth muscle and may be a potential therapeutic for asthma that has become resistant to standard therapies. Read MoreAug 15, 2016
-
New culprit in nerve degeneration
91Ʋ researchers have discovered that regulation of cell volume plays a role in nerve degeneration and peripheral neuropathies. Read MoreAug 12, 2016
-
NIH grant bolsters mass spectrometry research initiatives
The National Institutes of Health (NIH) has awarded a major renewal grant to continue the National 91Ʋ Resource for Imaging Mass Spectrometry at 91Ʋ University School of Medicine. Read MoreAug 11, 2016
-
Team explores transcription factor’s autoimmunity role
Increasing expression of a transcription factor called KLF2 can promote immunological self-tolerance and “tune down” autoimmunity, researchers at 91Ʋ University Medical Center reported recently. Read MoreAug 11, 2016
-
91Ʋ team takes aim at Ebola virus ‘decoy protein’
Using an antibody generated at 91Ʋ University Medical Center that neutralizes the Ebola virus, researchers at the Scripps 91Ʋ Institute in La Jolla, California, have determined the structure of a “decoy” protein that may enable the virus to evade detection by the immune system. Read MoreAug 11, 2016
-
Transcription factor evolution
91Ʋ researchers have discovered a novel model of evolution for factors that control gene expression. Read MoreAug 11, 2016
-
Study explores low oxygen’s impact on antibody quality
Hypoxia (lack of enough oxygen) is bad for the body as a whole, but in the neighborhood where infection-fighting antibodies arise, may be important for keeping proper order. Read MoreAug 11, 2016
-
Study reveals neurotransmitter glutamate’s molecular structure
Terunaga Nakagawa, with colleagues from Japan and Oxford University in England, has discovered the bridgelike molecular structure of a mysterious glutamate receptor. Read MoreAug 11, 2016
-
HIV treatment and TB risk
Tuberculosis (TB) remains an important public health problem, particularly among people infected with the human immunodeficiency virus (HIV). Read MoreAug 4, 2016
-
Kleberg Foundation grant bolsters cancer drug discovery efforts
The Robert J. Kleberg Jr. and Helen C. Kleberg Foundation has awarded a $3 million grant to 91Ʋ-Ingram Cancer Center (VICC) investigators in support of VICC’s drug discovery program. The gift awarded over the next three years from the private, San Antonio, Texas-based foundation will enable VICC researchers to pursue the development of new compounds to block the activity of cancer-causing genes and proteins that had previously been considered “undruggable.” Read MoreAug 3, 2016
-
Fetal impact of antidepressants
Antidepressant use during pregnancy is common. Fetal exposure to the class of antidepressants known as selective serotonin reuptake inhibitors (SSRIs) is associated with the life-threatening condition PPHN (persistent pulmonary hypertension of the newborn), but a causal link has not been established. Read MoreAug 3, 2016
-
Refining neural circuitry
During development, neural circuits are remodeled – some synapses are eliminated and others are strengthened – to produce a mature, functional nervous system. Read MoreAug 2, 2016
-
Possible overeating antidote
The 2C-subtype of the serotonin receptor (5HT2C), which binds the neurotransmitter serotonin, plays an important role in regulating food intake and metabolism. Read MoreAug 1, 2016
-
Award bolsters study of alcohol’s impact on the brain
91Ʋ University researcher Danny Winder, Ph.D., has received a MERIT Award from the National Institute of Alcohol Abuse and Addiction (NIAAA), part of the National Institutes of Health, for his contributions to understanding how alcohol affects the brain. Read MoreJul 28, 2016
-
Seminar focuses on latest concussion research
Neuropsychologist Gary Solomon, Ph.D., recently weighed in on one of the hottest debates in sports medicine, asserting that research doesn’t support the popular theory that concussions put athletes at higher risk for psychiatric illness. Read MoreJul 28, 2016